注射用亚胺西瑞 | Merck Sharp & Dohme B.V. | 1.25g(C₁₂H₁₇N₃O₄S 0.5g,C₁₆H₂₆N₂O₅S 0.5g与C₁₂H₂₀N₄O₆S 0.25g) | Merck Sharp & Dohme LLC | 国药准字HJ20240140 | 2024-12-01 | 查看 |
泊沙康唑肠溶片 | Hetero Labs Limited | 100mg | Hetero Labs Limited | 国药准字HJ20240139 | 2024-12-01 | 查看 |
钆特酸葡胺注射液 | JSC“Farmak” | 15ml:5.654g(以钆特酸葡胺计) | JSC“Farmak” | 国药准字HJ20240158 | 2024-12-01 | 查看 |
注射用亚胺西瑞 | Merck Sharp & Dohme B.V. | 1.25g(C₁₂H₁₇N₃O₄S 0.5g,C₁₆H₂₆N₂O₅S 0.5g与C₁₂H₂₀N₄O₆S 0.25g) | Merck Sharp & Dohme LLC | 国药准字HJ20240141 | 2024-12-01 | 查看 |
甲磺酸沙非胺片 | Zambon S.p.A. | 100mg(按C₁₇H₁₉FN₂O₂计) | Zambon S.p.A. | 国药准字HJ20240143 | 2024-12-01 | 查看 |
达比加群酯胶囊 | Hetero Labs Limited | 150mg(以达比加群酯计) | Hetero Labs Limited | 国药准字HJ20240156 | 2024-12-01 | 查看 |
达比加群酯胶囊 | Hetero Labs Limited | 110mg(以达比加群酯计) | Hetero Labs Limited | 国药准字HJ20240155 | 2024-12-01 | 查看 |
达比加群酯胶囊 | Hetero Labs Limited | 75mg(以达比加群酯计) | Hetero Labs Limited | 国药准字HJ20240154 | 2024-12-01 | 查看 |
苹果酸舒尼替尼胶囊 | Dr. Reddy’s Laboratories Limited | 12.5mg(按C₂₂H₂₇FN₄O₂计) | Dr. Reddy’s Laboratories Limited | 国药准字HJ20240157 | 2024-12-01 | 查看 |
甲磺酸沙非胺片 | Zambon S.p.A. | 50mg(按C₁₇H₁₉FN₂O₂计) | Zambon S.p.A. | 国药准字HJ20240142 | 2024-12-01 | 查看 |
奥德昔巴特胶囊 | Ipsen Pharma | 400µg(按C₃₇H₄₈N₄O₈S₂计) | Patheon France | 国药准字HJ20240148 | 2024-12-01 | 查看 |
鱼油(3%)橄榄油中/长链脂肪乳/氨基酸(16)/葡萄糖(13%)注射液 | Fresenius Kabi AB | 1448ml [鱼油(3%)橄榄油中/长链脂肪乳注射液204ml;复方氨基酸(16)电解质注射液456ml;葡萄糖(13%)注射液788ml] | Fresenius Kabi AB | 国药准字HJ20240151 | 2024-12-01 | 查看 |
鱼油(3%)橄榄油中/长链脂肪乳/氨基酸(16)/葡萄糖(13%)注射液 | Fresenius Kabi AB | 1904ml [鱼油(3%)橄榄油中/长链脂肪乳注射液268ml;复方氨基酸(16)电解质注射液600ml;葡萄糖(13%)注射液1036ml] | Fresenius Kabi AB | 国药准字HJ20240152 | 2024-12-01 | 查看 |
注射用芦比替定 | PharmaMar AG | 4mg | GP PHARM, SA | 国药准字HJ20240149 | 2024-12-01 | 查看 |
奥德昔巴特胶囊 | Ipsen Pharma | 200µg(按C₃₇H₄₈N₄O₈S₂计) | PATHEON FRANCE | 国药准字HJ20240145 | 2024-12-01 | 查看 |
普托马尼片 | Mylan Ireland Limited | 200mg | Mylan Laboratories Limited | 国药准字HJ20240153 | 2024-12-01 | 查看 |
奥德昔巴特胶囊 | Ipsen Pharma | 600µg(按C₃₇H₄₈N₄O₈S₂计) | Patheon France | 国药准字HJ20240146 | 2024-12-01 | 查看 |
奥德昔巴特胶囊 | Ipsen Pharma | 1200µg(按C₃₇H₄₈N₄O₈S₂计) | Patheon France | 国药准字HJ20240147 | 2024-12-01 | 查看 |
倍氯米松福莫特罗吸入粉雾剂 | Chiesi Farmaceutici S.p.A. | 每个吸入器120吸,每吸含丙酸倍氯米松100μg和富马酸福莫特罗6μg,递送剂量为丙酸倍氯米松81.9μg和富马酸福莫特罗5.0μg。 | CHIESI FARMACEUTICI S.p.A. | 国药准字HJ20240144 | 2024-12-01 | 查看 |
鱼油(3%)橄榄油中/长链脂肪乳/氨基酸(16)/葡萄糖(13%)注射液 | Fresenius Kabi AB | 1206ml [鱼油(3%)橄榄油中/长链脂肪乳注射液170ml;复方氨基酸(16)电解质注射液380ml;葡萄糖(13%)注射液656ml] | Fresenius Kabi AB | 国药准字HJ20240150 | 2024-12-01 | 查看 |